Life sciences
Evidence intelligence for medical and scientific teams.
Medical, publications, and outcomes teams are accountable for an evidence base they can no longer see the reception of. Increasingly, that reception is mediated by systems that retrieve, summarize, and sometimes distort the record. This is instrumentation for that problem — measurement of the scientific evidence base, kept deliberately separate from promotional communication.
Publications
Whether the publication plan produced findable evidence.
A publication plan is judged on outputs. This measures the next step: whether those outputs are retrieved, cited, and represented correctly when the underlying question is asked.
- 01Publication plan coverage
- Check whether the publications a plan produced are actually retrieved when a clinician-style question is asked, and which planned outputs are structurally invisible.
- 02Abstracts and congress output
- Conference abstracts often carry the first evidence and the weakest metadata. Measure whether they are findable at all, and whether they are linked to the full publication that followed.
- 03Trial-to-publication linkage
- Registry identifiers, protocol papers, primary results, and secondary analyses frequently sit unlinked. Broken linkage is a discoverability defect with a concrete fix.
- 04Interpretation fidelity
- Where a publication is summarized, compare the summary against the study's own stated population, endpoint, and limitations. Overstatement is reported as a discrepancy, not scored away.
Medical affairs
What the evidence base looks like from the outside.
- 01Field question intelligence
- Understand which evidence surfaces for the questions medical teams are actually asked, and where the answer draws on older or weaker sources than the current record supports.
- 02Evidence gap identification
- Queries with no adequate supporting publication are the clearest input to an evidence generation plan. They are reported as gaps, not filled in with inference.
- 03Interpretation rehearsal
- Synthetic stakeholder panels stress-test how a scientific statement is read by different professional perspectives before it is finalized. Output is directional research intelligence, never a substitute for validated human data.
HEOR and market access
Economic and outcomes evidence is the easiest to lose.
- 01Dossier evidence visibility
- Economic and outcomes publications are frequently the least discoverable part of an evidence base. Measure whether they are retrieved alongside the clinical record.
- 02Comparator evidence
- See which comparator studies surface for the same questions, so an evidence submission is prepared against what a reader will actually find.
- 03Real-world evidence discoverability
- Registry analyses and database studies often lack the structured metadata that makes them retrievable. Metadata defects are itemized with the record they belong to.
Patient engagement
Plain language, measured against the source.
- 01Plain-language availability
- Where a plain-language summary exists, check whether it is machine-readable and linked to the underlying publication. Where it does not exist, that absence is reported.
- 02Readability without distortion
- Simplification is measured against the source. A summary that reads more easily but overstates the finding is flagged as a fidelity problem.
- 03Transparent materials
- Any distribution material produced through the product is attributable and disclosed. There is no anonymous or unattributed channel.
Medical communications
Grounded briefing, with a review trail.
- 01Evidence-grounded briefing
- Start from what the literature says and what is retrievable, so a communications plan is built on the current evidence record rather than an internal recollection of it.
- 02Review states and trails
- Drafts move through review, and approved exports record the approver and the methodology version. Promotional workspaces cannot export without passing review.
- 03Agency collaboration
- Agency partners work inside a scoped role with their own audit trail, rather than through shared credentials.
Compliance boundaries
What this product will not do.
These are product boundaries, not policy preferences. They constrain what can be built, and they are stated here so a compliance reviewer can evaluate them before a pilot begins.
- 01No undisclosed advocacy
- Trace does not create, operate, or automate undisclosed advocacy. It does not generate synthetic endorsements, fabricated testimonials, or accounts that present themselves as independent parties.
- 02No synthetic engagement
- There is no capability to post as a real person, inflate engagement, or place content without attribution. Simulation of stakeholder reaction happens in a sandbox with no path to any live platform.
- 03Scientific exchange is not promotion
- The product distinguishes scientific evidence intelligence from promotional communication. A workspace declares which it is, and promotional workspaces carry mandatory review before anything leaves the system.
- 04Simulated output is labelled
- Every synthetic panel result is labelled as simulated in the interface and again in every export. It is directional input, not survey data, and it must not be presented as evidence of clinician opinion.
- 05No claim generation
- The product measures and reports. It does not draft product claims, and it does not substitute for medical, legal, and regulatory review of any material intended for external use.
- 06Reconstructable record
- Runs, approvals, exports, and deletions are logged so an internal reviewer can reconstruct what was produced, by whom, and against which methodology version.
Not a substitute for review
Nothing here replaces medical, legal, and regulatory review, and nothing here is regulatory advice. Trace makes no compliance certification claim of any kind. Determinations about the promotional or non-promotional character of a given communication remain with the customer.
Next step
Start with a portfolio you already know.
The most informative pilot is a therapeutic area your team knows in detail, because you can immediately tell whether a measurement is describing reality. Enterprise pilots are available now.